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  EVIDENCE-BASED ANSWER 
Evidence is insufficient to recommend for or against universal screening of young children for lead poisoning in 
high-prevalence communities (strength of recommendation [SOR]: C). In low-prevalence communities, 
evidence is insufficient to recommend for or against a targeted screening approach, employing locale-specific 
demographic risk factors and personal risk questionnaires to inform screening decisions (SOR: C). 
Although evidence does not suggest that treatment of individuals with elevated blood lead levels improves 
individual outcomes, public health strategies aimed at decreasing lead in the environment appear to have 
resulted in a significant decline in the number of children with elevated blood lead levels in recent decades. 
One could thus argue that screening may identify communities with high rates of lead poisoning, where 
environmental strategies could be targeted. 
Because the epidemiology of lead poisoning continues to change, local and state health authorities must 
continuously update information on which to base decisions about screening. 
  EVIDENCE SUMMARY 
The prevalence of elevated blood lead levels varies widely among different demographic groups and 
geographic regions, and it has decreased dramatically in the last several decades. Racial and ethnic minorities 
and children of families with low incomes, who live in the Northeast or Midwest, or who live in older houses 
continue to be at increased risk.1 Children with blood lead levels 10 μg/dL have been shown to have poorer 
cognitive and behavioral functioning.2 
No studies have demonstrated that screening for lead poisoning improves outcomes. To justify screening, one 
must therefore extrapolate from indirect evidence, demonstrating that screening tests are accurate and that 
treatment of children detected by screening is effective. Capillary blood samples are comparable with venous 
samples for detecting elevated blood lead levels. The sensitivity of capillary samples ranges from 86% to 96% 
compared with venous samples.3 
In low-prevalence areas, questionnaires may inform screening decisions. A questionnaire inquiring about age 
of housing, presence of peeling paint, ongoing renovations, siblings or playmates with elevated blood lead 
levels, adults in the home with occupational exposures to lead, and proximity to industrial sources of lead has a 
sensitivity for detecting blood lead levels 10 μg/dL ranging from 32% to 87%. Sensitivity varies depending on 
the population and geographic location in which the questionnaire is tested. Accuracy is improved by tailoring 
the questionnaire based on locally important risk factors.4 
Proposed treatments for elevated blood lead levels include chelation therapy, education about hygiene and 
nutrition, household dust control measures, and soil lead abatement. No good-quality trials have demonstrated 
that lowering slightly to moderately elevated blood lead levels (10–55 μg/dL) improves patient-oriented 
outcomes such as cognitive and behavioral functioning. Although 1 observational study of chelation therapy 
linked lowering blood lead levels with improved cognitive function,3 a randomized controlled trial showed that 
chelation had no effect on cognitive or behavioral outcomes.5 
All other trials evaluating treatment for lead poisoning looked at the intermediate outcome of blood lead levels. 
A systematic review of randomized controlled trials showed that home dust control interventions reduced the 
proportion of children with elevated blood lead levels (15 μg/dL) from 14% to 6%.6 A randomized controlled trial 
of high-efficiency particulate air (HEPA) filtration vacuuming showed no effect.7 More intensive interventions 
such as soil lead abatement and paint remediation have not proven effective in good-quality randomized 
controlled trials. 
Increasing dietary calcium and iron and decreasing dietary fat are also commonly recommended for children 
with elevated blood lead levels, based on animal models and cross-sectional studies. The only randomized 
controlled trial that investigated calcium supplementation showed no effect on blood lead levels.8 Our search 
revealed no good-quality studies on the effect of iron or fat intake on lead poisoning. 
In summary, because the prevalence of lead poisoning varies between communities and continues to change, 
standard recommendations are not possible. Clinicians must rely on local epidemiologic data to make 
screening decisions. Although questionnaires are accurate in predicting elevated blood lead levels in some 
settings, no specific set of questions can be recommended for all populations. 
No treatment options for those with mild to moderate elevations in blood lead levels have been shown to 
improve clinically important outcomes, although some interventions may decrease blood lead levels. 
  RECOMMENDATIONS FROM OTHERS 
The Centers for Disease Control and Prevention (CDC) recommends 
• that individual states develop screening plans based on local data 
• universal screening at 12 and 24 months of age: 
o in communities where the prevalence of blood lead levels ≥10 μg/dL exceeds 12% of 
children 
o in communities where ≥27% of housing was built before 1950 
o for all children enrolled in Medicaid. 
Otherwise screening should be targeted based on a questionnaire on age of housing, recent or ongoing 
remodeling, and having a sibling or playmate diagnosed with lead poisoning, in addition to questions on locally 
important risk factors.9 
The American Academy of Pediatrics endorses the CDC recommendations.2 The US Preventive Services Task 
Force, the American Academy of Family Physicians, and the American College of Preventive Medicine all 
recommend screening for lead poisoning at 12 months of age in children with demographic or geographic risk 
factors.3,10,11 
CLINICAL COMMENTARY 
Lead screening: Think locally 
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The local health department can provide information about lead screening in your 
community, whether based on blood levels or the housing conditions. If your patients need 
screening, you may want to add a reminder on a flow sheet in the chart to do a 
questionnaire or a blood draw. Finding and treating severely elevated lead levels can 
change outcomes, but for less elevated levels, the evidence shows no benefit. You should 
work with the health department when considering therapy for children with elevated blood 
lead levels. 
R E F E R E N C E S  
1. Kaufmann  RB, Clouse  TL, Olson  DR, Matte  TD. Elevated blood lead levels and 
blood lead screening among US children aged one to five years: 1988–1994. 
 Pediatrics 2000;106:E79. 
2. Screening for elevated blood lead levels. American Academy of Pediatrics 
Committee on Environmental Health.  Pediatrics 1998;101:1072–1078. 
3. US Preventive Services Task Force.  Guide to Clinical Preventive Services.  2nd 
ed. Baltimore, Md: Lippincott Williams & Wilkins; 1996. 
4. Binns  HJ, LeBailly  SA, Fingar  AR, Saunders  S. Evaluation of risk assessment 
questions used to target blood lead screening in Illinois.  Pediatrics 1999;103:100–
106. 
5. Rogan  WJ, Dietrich  KN, Ware  JH , et al.  The effect of chela-tion therapy with 
succimer on neuropsychological development in children exposed to lead.  N Engl J 
Med 2001;344:1421–1426. 
6. Haynes  E, Lanphear  BP, Tohn  E, Farr  N, Rhoads  GG. The effect of interior lead 
hazard controls on children’s blood lead concentrations: a systematic evaluation. 
 Environ Health Perspect 2002;110:103–107. 
7. Hilts  SR, Hertzman  C, Marion  SA. A controlled trial of the effect of HEPA 
vacuuming on childhood lead exposure.  Can J Public Health 1995;86:345–350. 
8. Ballew  C, Bowman  B. Recommending calcium to reduce lead toxicity in children: a 
critical review.  Nutr Rev 2001;59(3 Pt 1):71–79. 
9. Centers for Disease Control and Prevention.  Screening Young Children for Lead 
Poisoning: Guidance for State and Local Public Health Officials. Atlanta, Ga: CDC, 
1997. 
10. AAFP Policy Recommendations for Periodic Health Examinations 2002.   Available 
at http://www.aafp.org/ exam.xml. Accessed on February 9, 2003. 
11. Lane  WG, Kemper  AR. American College of Preventive Medicine Practice Policy 
Statement. Screening for elevated blood lead levels in children.  Am J Prev 
Med 2001;20:78–82.  
 
